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We investigated the prognostic value of normal predischarge exercise test in 109 patients after myocardial
infarction treated with i.v. thrombolysis within 4 h. In 29 of these 109 patients, elective PTC A or bypass
surgery was performed for prognostic reasons after coronary angiography; 80 patients were treated conserva-
tively with drug therapy. Recurrent postinfarct angina early after hospital discharge was the reason in 4 of 80
for PTC A or bypass surgery. Twenty-three of the remaining 76 conservatively treated patients developed
recurrent ischaemia during long-term follow-up of 120 ±6-2 months, including one patient with reinfarction.
Late recurrent ischaemia during long-term follow-up was observed in one third of the conservatively treated
patients with a normal predischarge exercise test, although a high percentage (30%) of patients in this
subgroup had been treated with PTCA or bypass surgery mainly for prognostic reasons. Predischarge exercise
test is therefore of limited value for detection of still viable myocardium at risk of further ischaemic events after
acute myocardial infarction and thrombolysis.
Introduction
Systemic thrombolysis in acute myocardial
infarction with recanalization of the infarct-related
coronary artery results in an improved myocardial
function and survival'1"6'. Thrombolysis is therefore
an established method of active treatment in the
early stage of acute myocardial infarction. How-
ever, the subsequent management of these patients
is controversial.
While early diagnostic and therapeutic inter-
vention during the first 24-48 h is not advantageous
because of more frequent bleeding complications
and a higher reocclusion rate17"9', a rational risk
stratification remains to be defined. There are still
no reliable non-invasive methods to establish and
measure the salvage of initially jeopardized myo-
cardium by thrombolysis. Risk stratification and
indication for invasive and expansive diagnostic
procedures like coronary angiography or thallium-
201 scintigraphy are frequently based on the results
of the predischarge exercise test"01", just as in
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patients with conservatively treated myocardial
infarction.
We therefore investigated the long-term follow-
up of patients after thrombolytic treatment of acute
myocardial infarction and its relationship to the
results of the predischarge exercise test.
Patients and methods
This analysis includes all patients who have
received thrombolytic therapy for acute myocardial
infarction in one of the eight hospitals of the
Zurich Study Group of Thrombolysis for Acute
Myocardial Infarction between 1986 and 1988. The
participating hospitals were: Triemli Hospital
Zurich, University Hospital Zurich, Waid Hospital
Zurich, Limmattal Hospital Zurich, Kantonsspital
St Gallen, Kantonsspital Winterthur, District
Hospital Uster and District Hospital Wetzikon.
PROTOCOL
Patients were considered eligible for thromboly-
sis if they were below the age of 70 years, com-
plained of typical chest pain of < 3-4 h duration
and showed ST-elevation in two leads of the electro-
cardiogram typical of acute transmural myocardial
ischaemia, in one lead at least measuring ^ 2 mm
0195-668X, 90/100897 + 06 $03.00/0 © 1990 The European Society of Cardiology
898 B. E. Marx et al.
and persisting after oral or intravenous nitrogly-
cerin. The exclusion criteria were: haemorrhagic
diathesis; uncontrolled hypertension (systolic
blood pressure £ 200 mmHg, diastolic blood press-
ure ^120 mmHg), previous arterial punction or
i.m. injection without possibility of local com-
pression; peptic ulcer disease, history of gastro-
intestinal or urogenital bleeding in the past 3
months; history of stroke within the past 6 months;
surgery in the past 6 weeks; arrhythmias requiring
immediate transvenous pacing; cardiopulmonary
resuscitation with external cardiac massage; any
severe disease that would exclude the patient in the
opinion of the treating physician.
THROMBOLYTIC THERAPY
Thrombolytic therapy was performed with either
streptokinase 1-5 Mio I.U. i.v. or with rt-PA in a
total dose of 100 mg i.v.
POST-FIBRINOLYTIC TREATMENT
Immediately after thrombolysis intravenous
heparin therapy was started, followed by oral anti-
coagulation for at least 6 months (1986 to 1987).
Starting in 1987 patients received acetylsalicylic
acid 500 mg i.v., additionally, instead of oral anti-
coagulants, aspirin 100-300 mg day"1 was pre-
scribed. The concomitant medication was left to the
treating physician.
CORONARY ANGIOGRAPHY
According to the uniform management every
patient underwent coronary angiography if he did
not show any contraindication for a possibly suc-
ceeding invasive therapy. Coronary angiography
was performed preferentially during the same
hospital stay, but not earlier than 72 h after
thrombolytic therapy.
EXERCISE TEST
For risk stratification, a submaximal exercise test
(bicycle ergometry or treadmill exercise test) was
performed according to the guidelines of the
European Society of Cardiology1121 before hospital
discharge. Horizontal or down-sloping ST-segment
depression of £ 1 mm, decrease in systolic blood
pressure of ^10 mmHg and angina were con-
sidered typical signs of ischaemia. If a secondary
preventive therapy with beta-blocker and aspirin
had been installed during hospitalization this
therapy remained unchanged for exercise test.
LONG-TERM FOLLOW-UP
In a limited pilot group a follow-up telephone call
was made to 36 patients after 20-5 ±5-7 months.
Patients (n = 132) who received thrombolysis there-
after were controlled prospectively by each centre.
Information was collected as to recurrent myocar-
dial infarction, presence of angina (New York
Heart Association classification), congestive heart
failure, invasive therapy (PTCA, bypass surgery)
and to medication; further a clinical examination
and a symptom-limited exercise test was performed.
DATA COLLECTION
The complete patient data were sent to a central
registry for statistical analysis. To evaluate stat-
istical significance the chi-square-test and the
two-tailed Fisher's exact test were used.
Results
PATIENT POPULATION AND FOLLOW-UP
195 patients hospitalized with acute myocardial
infarction from 1986 to 1988 in the intensive care
units of the eight participating hospitals received
i.v. thrombolytic therapy.
Six of the 195 patients (3%) died in hospital. No
predischarge exercise test was performed in 16
patients with unstable angina who instead received
early coronary angiography and invasive therapy.
Five patients could not be tested for non-cardiac
reasons. Thus, 168 patients underwent submaximal
predischarge exercise testing.
Sixteen of 168 patients were lost to follow-up
(15 with a normal predischarge exercise test, one
with exercise-induced ischaemia). Among 152
patients given the predischarge exercise test long-
term follow-up was made after 120±6-2 months
(range 3-31 months, median 12 months). The
characteristics of these 152 patients are shown in
Table 1.
TIME OF PREDISCHARGE EXERCISE TEST
The predischarge exercise test was performed
15-8±60 days after myocardial infarction. The
mean hospital stay was 17-5 ± 6-4 days.
FOLLOW-UP OF PATIENTS WITH ISCHAEMIA DURING
PREDISCHARGE EXERCISE TEST
From the 43 patients with ischaemic signs in the
predischarge exercise test, 27 (63%) were treated
invasively; 16 (37%) did not qualify for PTCA or
coronary artery bypass grafting (CABG) because of
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Table I Characteristics of patients with predischarge exercise test and known follow-up
Patient characteristics
Number of patients (n)
Age (years; mean ± SD)
Male:female
Infarct localization
ant:inf/post (%)
Coronary angiography (%)
Vessel patency (%)
Predischarge exercise test
(days; mean ± SD)
Hospitalization
(days; mean ± SD)
Follow-up (months)
Predischarge exercise test
no ischaemia
total
152
57-O±8-2
11:1
46:54
85
83
15 8 ± 6 0
17-5±6-4
120±6 2
ischaemia
43
55-8 ±70
42:1
41:59
93
80
16-2±5-4
18-8 ±6-4
12-8±6-2
no ischaemia
109
57-5±8-6
8:1
49:51
82
84
15-6 ±6-2
170±6-3
11-6±6-2
n = IO9
I
coronary angiography (82%)
invasive therapy
29 (27%)
33 (30%)
non-invasive therapy
80 (73%)
follow-up
76 (70%)
uchaemio - I -
30% (23)
Figure 1 Primary therapy and follow-up of 109 patients without
ischaemia at predischarge exercise test.
unfavourable coronary anatomy and/or prohibi-
tive left ventricular function; one of the patients had
died during the follow-up period with recurrent
myocardial infarction, four patients were still suf-
fering from angina NYHA class II—III, and one
patient showed exercise-induced silent myocardial
ischaemia despite antiischaemic drug treatment.
FOLLOW-UP RESULTS OF PATIENTS WITH ISCHAEMIA
DURING PREDISCHARGE EXERCISE TEST (FIG. 1)
In the group of patients without ischaemia during
predischarge exercise test (n=109), primary
invasive treatment was chosen in 29 patients (27%)
for prognostic reasons (left main coronary artery
stenosis, three-vessel disease with impaired left ven-
tricular function; residual high-grade stenosis of the
infarct-related coronary artery with preserved
regional contractility). Four additional patients
received coronary angiography and invasive ther-
apy as they developed postinfarct angina soon after
hospital discharge. Among the remaining 76
patients at follow-up, 30% (n = 23) showed recur-
rent myocardial ischaemia: in one patient reinfarc-
tion occurred, 20 patients complained of angina
NYHA class II—III, in two patients signs of
ischaemia were present only during a symptom-
limited exercise test. One patient with left ventricu-
lar aneurysm and therapy-resistant ventricular
tachycardia had died.
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Table 2 Drug therapy at I-yearfollow-up in patients with normal predischarge exercise test and
primary conservative therapy
Drug therapy Ischaemia at follow-uppresent n = 23 absent n*= 52
Antianginal therapy
Beta blockers
Ca-antagonists
Nitrates
Molsidomine
Platelet aggregation inhibitors
Anticoagulants
19 (83%)
11 (48%)
7 (30%)
10 (43%)
3 (4%)
6 (26%)
11 (47%)
40
23
17
10
2
23
11
(77%)
(44%)
(33%)
(19%)
(38%)
(44%)
(21%)
primary PTCA/bypass
secondary PTCA/bypass
schaemia at follow-up
Figure 2 Normal predischarge exercise test (n=109): final
results of follow-up after 1 year.
No signs of ischaemia were present in 52 patients
(69%).
DRUG THERAPY AT FOLLOW-UP
The drug therapy given to non-invasively treated
patients with a normal predischarge exercise test is
summarized in Table 2.
Discussion
Thrombolytic therapy in acute myocardial
infarction aims at early re-establishment of coron-
ary reperfusion and salvage of myocardium. After
successful thrombolysis, mortality rate has been
shown to be significantly reduced. There are, how-
ever, controversies as to the preferable post-
thrombolytic strategy. The results from recent trials
like TAMI and TIMI II favour elective angioplasty
instead of an immediate invasive procedure'7'9131. As
the comparison between the randomly assigned
invasive and conservative strategy in the TIMI II
trial showed no significant differences in reinfarction
and death rate after short-term follow-up (maxi-
mum 42 days), 'watchful waiting' was recommended
after thrombolysis and restriction of coronary
angiography to patients with either spontaneous
postinfarct angina or to patients with ischaemia
developing during predischarge exercise test1131.
In the present investigation coronary angio-
graphy was, according to a uniform protocol,
performed in every patient who had received
thrombolysis. A prognostic indication such as left
main coronary artery stenosis, three-vessel disease
with impaired left ventricular function or residual
high-grade stenosis of the infarct-related coronary
artery with preserved regional contractility, was the
reason for primary invasive therapy in 27% of the
109 patients with normal predischarge exercise test
(Fig. 2). A further 4% of patients underwent angio-
plasty or bypass surgery early after hospital dis-
charge because of recurrent severe postinfarct
angina. Despite this high initial rate of CABG and
PTCA, recurrent ischaemia was observed after 1
year of follow-up in 21 % of the patients with a nor-
mal predischarge exercise test; a surprisingly high
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percentage considering that 83% of these patients
were still taking antianginal drugs—half of them
beta-blockers (Table 2). Only 48% of patients
remained free of symptomatic or silent ischaemia at
exercise; they were taking anti-ischaemic medi-
cation in 77% (beta-blocker therapy and platelet
aggregation inhibitors in 44% each).
Considering our results, doubts must arise about
the significance of predischarge exercise test rec-
ommended for risk stratification in patients with
thrombolytic therapy for acute myocardial infarc-
tion: in all our patients without contraindication for
a succeeding invasive therapy coronary angio-
graphy was performed (85%) and, according to the
coronary lesions, one fourth of the patients with
initially normal predischarge exercise test received
an invasive procedure for prognostic reasons. In
addition to early recurrent ischaemia in 4%, late
recurrent ischaemia developed in 21% of the
remaining patients. Submaximal predischarge exer-
cise testing, which was performed in our study
according to the guidelines of the European Society
of Cardiology1121, showed identical predictive accur-
acy to symptom-limited postdischarge exercise test-
ing in patients 6 weeks after conservatively treated
myocardial infarction'141. However, similar investi-
gations have not been performed in patients after
thrombolytic treatment for acute myocardial
infarction.
An important factor contributing to late recur-
rent ischaemia after thrombolysis is the problem of
stunned myocardium which may persist for weeks
and months'15161. In a recent study Weiss et al.
showed that by quantifying viable myocardium
with thallium-201 scintigraphy before and after
thrombolysis, the ratio of salvaged to initially
jeopardized myocardium is predictive of exercise-
induced ischaemia; this ratio was found to be
inversely related to the severity of the residual
coronary stenosis'171. Whereas exercise-induced
ischaemia was recognized with radionuclide study
in 64%, it was identified at treadmill exercise elec-
trocardiography with significant ST-depression or
angina in only 35%, thus confirming the low sensi-
tivity and predictive accuracy of exercise testing for
detecting residual ischaemia in patients after
thrombolysis. This finding concurs with our data
and is further supported by the results of the TIMI
II Study1'81, in which among patients randomly
assigned to conservative therapy, 220% and 16-5%
required PTCA and/or bypass surgery, respect-
ively, because of recurrent myocardial ischaemia
developing within 1 year of follow-up.
An accurate, highly sensitive and cost-effective
method to detect residual ischaemia of viable myo-
cardium in patients after thrombolytic therapy for
acute myocardial infarction, is not yet available:
bicycle ergometry and treadmill exercise testing
are not sensitive enough; thallium-201 scintigraphy
is somewhat superior to submaximal predis-
charge exercise testing in detecting myocardial
ischaemia''91, however, compared with parallel
examination with positron emission tomography,
which identifies metabolically active tissue, it does
not reach 100% accuracy and still underestimates
the extent of salvaged myocardium120"221.
Considering the generally good prognosis for
survival and reinfarction after thrombolysis, the
significance of late recurrent ischaemia in an even
longer observation period remains unclear. In our
opinion, risk stratification should include exercise
testing and generously performed coronary angio-
graphy, at least until the role of coronary angio-
graphy after acute myocardial infarction and
thrombolysis has precisely been established, to
identify low-risk patients who might be discharged
from hospital early*231 and high-risk patients who
should be treated invasively without delay. Such a
strategy should save costs in the long term.
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